What is the current stock price of THX Pharma (ALTHX.PA)?

As of the latest market data, THX Pharma (ALTHX.PA) is trading at $0.00. The stock has seen a loss of undefined% today.

Does THX Pharma (ALTHX.PA) pay a dividend?

Based on current data, THX Pharma does not have a confirmed active dividend policy.

What is the market cap of THX Pharma?

The current market capitalization of THX Pharma (ALTHX.PA) is approximately unavailable.

ALTHX.PA

THX Pharma·Healthcare

0.00

0.000%(+0.00)

Market Closed

Last Updated: — ET

52W L: $0.0052W H: $0.00

Company Profile

Theranexus société anonyme, a biopharmaceutical company, develops drug candidates for the treatment of central nervous system disorders. The company's lead drug candidate is THN102, which is in Phase II clinical trial to treat sleep/wake disorders. It also develops THN201 for the treatment of neurocognitive disorders linked to Alzheimer's disease; and THN101 to treat neuropathic pain. The company was founded in 2013 and is based in Lyon, France.

Sector

Healthcare

Industry

Medical - Pharmaceuticals

Employees

IPO Date

2017-10-30

Beta

1.54

Websitewww.theranexus.com↗